| In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model IP Williams, S Crescioli, HS Sow, HJ Bax, C Hobbs, KM Ilieva, E French, ... mAbs 12 (1), 1685349, 2020 | | 2020 |
| In Planta Glycan Engineering and Functional Activities of IgE Antibodies L Montero-Morales, D Maresch, S Crescioli, A Castilho, KM Ilieva, S Mele, ... Frontiers in bioengineering and biotechnology 7, 242, 2019 | | 2019 |
| IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states G Pellizzari, C Hoskin, S Crescioli, S Mele, J Gotovina, G Chiaruttini, ... EBioMedicine 43, 67-81, 2019 | 3 | 2019 |
| AllergoOncology: expression platform development and functional profiling of an anti-HER2 IgE antibody KM Ilieva, J Fazekas-Singer, HJ Bax, S Crescioli, L Montero-Morales, ... Allergy 74 (10), 1985, 2019 | 2 | 2019 |
| Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment M Georgouli, C Herraiz, E Crosas-Molist, B Fanshawe, O Maiques, ... Cell 176 (4), 757-774. e23, 2019 | 12 | 2019 |
| Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... Frontiers in immunology 10, 2019 | 12 | 2019 |
| Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer A Cheung, J Opzoomer, KM Ilieva, P Gazinska, RM Hoffmann, H Mirza, ... Clinical Cancer Research 24 (20), 5098-5111, 2018 | 5 | 2018 |
| Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells S Mele, S Devereux, AG Pepper, E Infante, AJ Ridley Blood advances 2 (13), 1551-1561, 2018 | 4 | 2018 |
| Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology S Crescioli, G Chiaruttini, S Mele, KM Ilieva, G Pellizzari, DIR Spencer, ... Journal of Allergy and Clinical Immunology 141 (4), 1519-1523. e9, 2018 | 5 | 2018 |
| Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs) RM Hoffmann, BGT Coumbe, DH Josephs, S Mele, KM Ilieva, A Cheung, ... Oncoimmunology 7 (3), e1395127, 2018 | 18 | 2018 |
| In vitro and in vivo evidence for uncoupling of B-cell receptor internalization and signaling in chronic lymphocytic leukemia EM Coulter, A Pepper, S Mele, W Townsend, K Cuthill, EH Phillips, ... haematologica 103 (3), 497-505, 2018 | 1 | 2018 |
| Chondroitin sulfate proteoglycan 4 and its potential as an antibody immunotherapy target across different tumor types KM Ilieva, A Cheung, S Mele, G Chiaruttini, S Crescioli, M Griffin, ... Frontiers in immunology 8, 1911, 2018 | 12 | 2018 |
| Actitudes hacia el pasado, valores, dominancia social y propósito en la vida: un estudio sobre las huellas de la última dictadura militar argentina JI Bombelli, S Mele, E Zubieta, M Muratori Universidad Nacional de Lomas de Zamora. Facultad de Ciencias Sociales, 2018 | | 2018 |
| King’s Research Portal S Crescioli, G Chiaruttini, S Mele, KM Ilieva, G Pellizzari, DIR Spencer, ... | | 2018 |
| Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells. Blood Advances, 2 (13), 1551-1561. S Mele, S Devereux, AG Pepper, E Infante, A Ridley | | 2018 |
| Uncoupling of BCR internalization and signaling in normal and chronic lymphocytic leukemia B-cells E Coulter, A Pepper, S Mele, N Folarin, W Townsend, K Cuthill, E Phillips, ... LEUKEMIA & LYMPHOMA 58, 121-122, 2017 | | 2017 |
| BRAF inhibitors: resistance and the promise of combination treatments for melanoma M Griffin, D Scotto, DH Josephs, S Mele, S Crescioli, HJ Bax, G Pellizzari, ... Oncotarget 8 (44), 78174, 2017 | 34 | 2017 |
| Functionally active Fc mutant antibodies recognizing cancer antigens generated rapidly at high yields KM Ilieva, J Fazekas-Singer, DY Achkova, TS Dodev, S Mele, S Crescioli, ... Frontiers in immunology 8, 1112, 2017 | 6 | 2017 |
| Allergooncology: Functional evaluation of SF-25 IgE and IgG1 antibodies as novel candidates to activate human effector cells for cancer immunotherapy G Pellizzari, S Crescioli, S Mele, G Chiaruttini, HJ Bax, DH Josephs, ... ALLERGY 72, 815-815, 2017 | | 2017 |
| B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment G Chiaruttini, S Mele, J Opzoomer, S Crescioli, KM Ilieva, KE Lacy, ... Oncoimmunology 6 (4), e1294296, 2017 | 24 | 2017 |
